Skip to main content

Scientists managed to “cut out” HIV virus from rats

hiv cure dna double helix
Image used with permission by copyright holder

Science has brought us yet another step closer to an HIV cure with a pair of molecular scissors. A group of researchers at the Lewis Katz School of Medicine at Temple University have managed to “cut out” HIV-1 genes from mice and rat genomes.

“In a proof-of-concept study, we show that our gene editing technology can be effectively delivered to many organs of two small animal models and excise large fragments of viral DNA from the host cell genome,” said Professor Kamel Khalili, who led the study. This, scientists hope, could one day lead to the elimination of the deadly virus in human patients as well.

Recommended Videos

Currently, HIV treatment is contingent upon a cocktail of antiretrovirals, and while these drugs can prevent the virus from replicating, it doesn’t serve as a real cure. Moreover, Temple University points out, “When antiretroviral therapy is interrupted, HIV replication rebounds, placing patients at risk for developing acquired immune deficiency syndrome, or AIDS.” But if doctors are able to fully remove the virus from human genomes altogether, a wholesale solution may finally be in sight.

Please enable Javascript to view this content

In conducting their experiment, researchers first infected rats with HIV DNA, then engineered an ex vivo experiment to “cleave the integrated HIV-1 DNA in the host cell genome.” This would potentially excise the viral DNA fragment from the genome altogether. After two weeks, the Temple University team examined their subjects’ DNA, and found that the HIV DNA was no longer present, seemingly removed from every tissue, including the brain, heart, kidney, liver, lungs, spleen, and blood cells.

“The ability of the rAAV delivery system to enter many organs containing the HIV-1 genome and edit the viral DNA is an important indication that this strategy can also overcome viral reactivation from latently infected cells and potentially serve as a curative approach for patients with HIV,” said Dr. Khalili.

The next step for Khalili’s team will be to conduct a larger study on animals, but the team hopes that a clinical trial for human patients could come to fruition within the next several years.

Lulu Chang
Former Digital Trends Contributor
Fascinated by the effects of technology on human interaction, Lulu believes that if her parents can use your new app…
U.S. EVs will get universal plug and charge access in 2025
u s evs will get universal plug charge access in 2025 ev car to charging station power cable plugged shutterstock 1650839656

And then, it all came together.

Finding an adequate, accessible, and available charging station; charging up; and paying for the service before hitting the road have all been far from a seamless experience for many drivers of electric vehicles (EVs) in the U.S.

Read more
Rivian tops owner satisfaction survey, ahead of BMW and Tesla
The front three-quarter view of a 2022 Rivian against a rocky backdrop.

Can the same vehicle brand sit both at the bottom of owner ratings in terms of reliability and at the top in terms of overall owner satisfaction? When that brand is Rivian, the answer is a resonant yes.

Rivian ranked number one in satisfaction for the second year in a row, with owners especially giving their R1S and R1T electric vehicle (EV) high marks in terms of comfort, speed, drivability, and ease of use, according to the latest Consumer Reports (CR) owner satisfaction survey.

Read more
Hybrid vehicle sales reach U.S. record, but EV sales drop in third quarter
Tesla Cybertruck

The share of electric and hybrid vehicle sales continued to grow in the U.S. in the third quarter, the Energy Information Administration (EIA) reported this month.

Taken together, sales of purely electric vehicles (EVs), hybrids, and plug-in hybrids (PHEVs) represented 19.6% of total light-duty vehicle (LDV) sales last quarter, up from 19.1% in the second quarter.

Read more